Stay updated on Fevipiprant in COPD With Eosinophilia Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant in COPD With Eosinophilia Clinical Trial page.

Latest updates to the Fevipiprant in COPD With Eosinophilia Clinical Trial page
- CheckyesterdayChange DetectedA sitewide banner announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the usual content, indicating access is blocked and the normal page cannot be viewed.SummaryDifference18%

- Check36 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new version of the study record.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a small internal update; no substantive study information is affected.SummaryDifference0.1%

- Check57 days agoChange DetectedA funding source entry '2018 ( U.S. NIH Grant/Contract )' was added under the study identifiers, updating the record to reflect NIH support.SummaryDifference0.1%

Stay in the know with updates to Fevipiprant in COPD With Eosinophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant in COPD With Eosinophilia Clinical Trial page.